Share on StockTwits
 

Rentokil Initial (LON:RTO) was upgraded by equities researchers at Cantor Fitzgerald Europe to a “buy” rating in a research report issued on Monday, AmericanBankingNews.com reports. The firm currently has a GBX 140 ($2.30) price target on the stock. Cantor Fitzgerald Europe’s target price points to a potential upside of 14.01% from the company’s current price.

RTO has been the subject of a number of other recent research reports. Analysts at Panmure Gordon downgraded shares of Rentokil Initial to a “sell” rating in a research note to investors on Friday, January 10th. They now have a GBX 97 ($1.59) price target on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Rentokil Initial in a research note to investors on Tuesday, December 17th. They now have a GBX 95 ($1.56) price target on the stock. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Rentokil Initial in a research note to investors on Tuesday, December 10th. They now have a GBX 117 ($1.92) price target on the stock. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Hold” and an average price target of GBX 101.43 ($1.67).

Shares of Rentokil Initial (LON:RTO) traded down 0.08% during mid-day trading on Monday, hitting GBX 122.70. The stock had a trading volume of 2,441,230 shares. Rentokil Initial has a one year low of GBX 85.70 and a one year high of GBX 124.00. The stock has a 50-day moving average of GBX 113.7 and a 200-day moving average of GBX 106.1. The company’s market cap is £2.219 billion.

Rentokil Initial plc is the holding company. Revenue is generated from pest control, hygiene, textiles, interior plants, facilities services and parcel delivery.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.